Status: Recruiting
Gastrointestinal Dysmotility on Aspiration Risk
The hypothesis of this study is that esophageal and gastric dysmotility increase the risk of developing aspiration-associated symptoms in children with neurologic impairment. The investigators are conducting a ten week cross over study comparing prucalopride to famotidine for the treatment of aspiration-associated symptoms.
Participants needed: 120
Trial details
Phase: Phase 4Age: 5-21Biological sex: AllType: InterventionalSponsor: Boston Children's HospitalUpdated: Dec 26, 2025Locations: 1
Eligibility criteria
are 5-21 years of age; [+4]
have progressive neurologic impairment; [+4]